8-Amino-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one

Catalog No.: 
ACSHNK437
CAS No.: 
1018254-91-5
Molecular Formula: 
C9H10N2O2
Molecular Weight: 
178.19
8-Amino-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%
100mg95%
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Amino-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
IUPAC Name8-amino-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
MDL No.MFCD09998374
Molecular FormulaC9H10N2O2
Molecular Weight178.19
SMILESO=C1N(C)C2=CC=CC(N)=C2OC1
InChI KeyTYHFSDSZRQLYEF-UHFFFAOYSA-N
Synonym8-Amino-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one;8-amino-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one;2H-1,4-Benzoxazin-3(4H)-one, 8-amino-4-methyl-
CAS No.1018254-91-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSHNK437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACSHNK437 route product structure diagram
    ACSHNK4371018254-91-5In Stock
Inquiry

2. ACSHNK437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHNK437 route product structure diagram
    ACSHNK4371018254-91-5In Stock
Inquiry

3. ACSHNK437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHNK437 route product structure diagram
    ACSHNK4371018254-91-5In Stock
Inquiry

Comments (0)